Short- and long-term outcomes of single bare metal stent versus drug eluting stent in nondiabetic patients with a simple de novo lesion in the middle and large vessel

Table 4 Clinical outcomes at 1-year and 3-year follow-up between DES group and BMS group

Events	1-year follow-up			3-year follow-up			Between 1-year and 3-year follow-up
Events	BMS group (N = 150 Pts)	DES group (N = 85 Pts)	P	BMS group (N = 150 Pts)	DES group (N = 85 Pts)	P	BMS group (N = 150 Pts)	DES group (N = 85 Pts)	P
Re-MI (%)	0	1.2	0.36	0	2.4	0.06	0	1.2	0.36
Cardiac death (%)	1.3	2.4	0.62	2.0	3.5	0.48	0.7	1.2	1.00
TLR (%)	4.7	4.7	1.00	6.0	5.9	0.97	1.3	1.2	1.00
MACE (%)	6.0	7.1	0.75	8.7	10.6	0.63	2.7	3.5	0.71

Note: Pts, patients; Re-MI, recurrent myocardial infarction; TLR, target lesion revascularization; MACE, major adverse cardiac events.

ISSN: 1479-5876